Heme oxygenase-1 plays a crucial role in chemoresistance in acute myeloid leukemia

Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1

(2015) Sally-Anne Heasman et al.   Oncotarget

Luteolin Sensitizes Two Oxaliplatin-Resistant Colorectal Cancer Cell Lines to Chemotherapeutic Drugs Via Inhibition of the Nrf2 Pathway

(2014) Song Chian et al.   Asian Pacific Journal of Cancer Prevention

HIF-1α and GLUT1 Gene Expression is Associated with Chemoresistance of Acute Myeloid Leukemia

(2014) Kui Song et al.   Asian Pacific Journal of Cancer Prevention

Heme Oxygenase-1 Drives Metaflammation and Insulin Resistance in Mouse and Man

(2014) Alexander Jais et al.   CELL

Eckol Enhances Heme Oxygenase-1 Expression through Activation of Nrf2/JNK Pathway in HepG2 Cells

(2014) Young-Jin Jun et al.   MOLECULES

Outcome of children treated for relapsed acute myeloid leukemia in Central America

(2014) Stacey Marjerrison et al.   PEDIATRIC BLOOD & CANCER

Carbon Monoxide Induces Heme Oxygenase-1 to Modulate STAT3 Activation in Endothelial Cells via S-Glutathionylation

(2014) Yan-Chang Yang et al.   PLoS One

Epidermal Growth Factor Stimulates Nuclear Factor-κB Activation and Heme Oxygenase-1 Expression via c-Src, NADPH Oxidase, PI3K, and Akt in Human Colon Cancer Cells

(2014) Gi-Shih Lien et al.   PLoS One

How does hypoxia inducible factor-1α participate in enhancing the glycolysis activity in cervical cancer?

(2013) Yanxiang Cheng et al.   Annals of Diagnostic Pathology

Haem oxygenase-1 induction reverses the actions of interleukin-1β on hypoxia-inducible transcription factors and human chondrocyte metabolism in hypoxia

(2013) Victoria Clérigues et al.   CLINICAL SCIENCE

Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair

(2013) C Barckhausen et al.   ONCOGENE

Inhibition of Glucose Transporter 1 (GLUT1) Chemosensitized Head and Neck Cancer Cells to Cisplatin

(2013) Yao-Dong Wang et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Impaired response of hypoxic sensor protein HIF-1α and its downstream proteins in the spinal motor neurons of ALS model mice

(2012) Kota Sato et al.   BRAIN RESEARCH

Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells

(2012) Yong Yang et al.   CELL BIOCHEMISTRY AND FUNCTION

M3-mAChR Stimulation Exerts Anti-apoptotic Effect Via Activating the HIF-1α/HO-1/VEGF Signaling Pathway in H9c2 Rat Ventricular Cells

(2012) Yang Hui et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression

(2012) W. Luo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells

(2011) Y. Zhou et al.   CANCER RESEARCH

Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance

(2011) Alina Shapira et al.   DRUG RESISTANCE UPDATES

Hypoxia-Inducible Factor-1  Is Constitutively Expressed in Murine Leydig Cells and Regulates 3 -Hydroxysteroid Dehydrogenase Type 1 Promoter Activity

(2009) J. J. Lysiak et al.   JOURNAL OF ANDROLOGY

HO-1 underlies resistance of AML cells to TNF-induced apoptosis

(2008) S. A. Rushworth et al.   BLOOD